Sol-Gel SLGL Stock
Sol-Gel Price Chart
Sol-Gel SLGL Financial and Trading Overview
| Sol-Gel stock price | 71.5 USD |
| Previous Close | 73.86 USD |
| Open | 74 USD |
| Bid | 70.52 USD x 200 |
| Ask | 73.5 USD x 200 |
| Day's Range | 68 - 75.45 USD |
| 52 Week Range | 6.8 - 97.97 USD |
| Volume | 39.64K USD |
| Avg. Volume | 41.42K USD |
| Market Cap | 230.14M USD |
| Beta (5Y Monthly) | 1.171 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.3 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 147 USD |
SLGL Valuation Measures
| Enterprise Value | 184.36M USD |
| Trailing P/E | N/A |
| Forward P/E | -6.470588 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 11.870073 |
| Price/Book (mrq) | 8.598998 |
| Enterprise Value/Revenue | 9.509 |
| Enterprise Value/EBITDA | -24.637 |
Trading Information
Sol-Gel Stock Price History
| Beta (5Y Monthly) | 1.171 |
| 52-Week Change | 920.16% |
| S&P500 52-Week Change | 27.69% |
| 52 Week High | 97.97 USD |
| 52 Week Low | 6.8 USD |
| 50-Day Moving Average | 73.68 USD |
| 200-Day Moving Average | 53.46 USD |
SLGL Share Statistics
| Avg. Volume (3 month) | 41.42K USD |
| Avg. Daily Volume (10-Days) | 43.01K USD |
| Shares Outstanding | 3.27M |
| Float | 463.29K |
| Short Ratio | 0.91 |
| % Held by Insiders | 60.13% |
| % Held by Institutions | 43.54% |
| Shares Short | 25.06K |
| Short % of Float | 2.43% |
| Short % of Shares Outstanding | 0.77% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | December 31, 2025 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | -31.60% |
| Operating Margin (ttm) | -497.84% |
| Gross Margin | -17.61% |
| EBITDA Margin | -38.59% |
Management Effectiveness
| Return on Assets (ttm) | -14.43% |
| Return on Equity (ttm) | -23.71% |
Income Statement
| Revenue (ttm) | 19.39M USD |
| Revenue Per Share (ttm) | 6.96 USD |
| Quarterly Revenue Growth (yoy) | 150.40% |
| Gross Profit (ttm) | -3416000 USD |
| EBITDA | -7483000 USD |
| Net Income Avi to Common (ttm) | -6127000 USD |
| Diluted EPS (ttm) | -0.3 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 24M USD |
| Total Cash Per Share (mrq) | 8.54 USD |
| Total Debt (mrq) | 991K USD |
| Total Debt/Equity (mrq) | 4.34 USD |
| Current Ratio (mrq) | 4.371 |
| Book Value Per Share (mrq) | 8.187 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 322K USD |
| Levered Free Cash Flow (ttm) | 617K USD |
Profile of Sol-Gel
| Country | United States |
| State | N/A |
| City | Ness Ziona |
| Address | 7 Golda Meir Street |
| ZIP | 7403650 |
| Phone | 972 8 931 3433 |
| Website | https://www.sol-gel.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 28 |
Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel, China, Switzerland, Canada, the United States and internationally. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea. It also develops SGT-610 that is in Phase 3 clinical trials for the treatment of Gorlin Syndrome; and SGT-210, which has completed Phase I clinical trial, to treat olmsted syndrome. It has collaboration with Padagis Israel Pharmaceuticals Ltd; and license agreements with Galderma Holding SA and Searchlight Pharma Inc. Sol-Gel Technologies Ltd. was incorporated in 1997 and is headquartered in Ness Ziona, Israel.
Q&A For Sol-Gel Stock
What is a current SLGL stock price?
Sol-Gel SLGL stock price today per share is 71.5 USD.
How to purchase Sol-Gel stock?
You can buy SLGL shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Sol-Gel?
The stock symbol or ticker of Sol-Gel is SLGL.
Which industry does the Sol-Gel company belong to?
The Sol-Gel industry is Biotechnology.
How many shares does Sol-Gel have in circulation?
The max supply of Sol-Gel shares is 3.25M.
What is Sol-Gel Price to Earnings Ratio (PE Ratio)?
Sol-Gel PE Ratio is now.
What was Sol-Gel earnings per share over the trailing 12 months (TTM)?
Sol-Gel EPS is -0.3 USD over the trailing 12 months.
Which sector does the Sol-Gel company belong to?
The Sol-Gel sector is Healthcare.
Sol-Gel SLGL included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| US Tech Composite IXIC | 26853.98 USD — |
-0.89
|
8.32B USD — | 26769.16 USD — | 27130.88 USD — | — - | 8.32B USD — |
| US Tech Global Market Composite NQGM | 2296 USD — |
-1.38
|
— — | 2280.64 USD — | 2323.09 USD — | — - | — — |
| US Tech Health Care IXHC | 1133.51 USD — |
+1.54
|
— — | 1113.35 USD — | 1133.95 USD — | — - | — — |
- {{ link.label }} {{link}}